The startup develops reformulated biopharmaceutical drugs that utilize new chemical entities to enhance the identification of biologics and small molecules. This approach streamlines regulatory strategies and clinical programs, enabling biotech companies to efficiently meet drug demands and improve patient outcomes.

Blues Wireless provides embedded cellular solutions for Internet of Things (IoT) devices, enabling seamless connectivity in remote and challenging environments. Their technology addresses the need for reliable, low-power communication in applications where traditional connectivity options are insufficient.

Carta Healthcare combines artificial intelligence with expert clinical data abstractors to enhance the speed and quality of clinical data abstraction for healthcare registries. This approach addresses the inefficiencies of traditional data abstraction methods, which are often time-consuming, labor-intensive, and costly, by delivering high-quality data more efficiently.

Censinet provides a cloud-based risk exchange platform, Censinet RiskOps, that facilitates secure sharing of cybersecurity and risk data among healthcare delivery organizations and third-party vendors. This platform accelerates third-party risk assessments and enhances cybersecurity program coverage, ensuring the protection of patient data and care operations.

Emergo Therapeutics is developing Norketotifen, a treatment that modulates the immune system to reduce hypercytokinemia associated with long COVID and influenza-like illnesses. This approach targets the overactive release of inflammatory cytokines without causing immunosuppression, addressing a significant gap in effective treatments for these conditions.

Gauss is a mobile application that provides a low-interest credit line to pay off high-APR credit card balances, enabling users to reduce interest costs and accelerate debt repayment. The platform also offers personalized financial advice and rewards for timely payments, helping users improve their credit scores while managing multiple credit cards efficiently.

HARM provides an AI-powered platform for individuals experiencing harm to quickly access immediate, trusted support. The system intelligently identifies the nature of the reported harm and routes users directly to appropriate, city-approved advocacy, legal, or housing resources. This streamlined process eliminates confusion while generating de-identified data insights to help municipal leaders optimize community support services.

HERO Medical Technologies develops specialized bandaging solutions for complex head injuries and limb wounds, utilizing conformable materials that adapt to irregular shapes. This technology enhances emergency care efficiency and minimizes complications during critical medical situations.

O is developing an IoT device that visualizes the human circadian clock to enhance individual and organizational performance through data-driven insights. The platform provides actionable recommendations based on sleep data, addressing productivity issues and mental health risks within teams.

Phononic develops solid-state cooling technology that eliminates the need for bulky compressors and toxic refrigerants, providing efficient thermal management for applications in data centers, cold chain logistics, and HVAC systems. Their solutions enhance energy efficiency and reduce operational costs while ensuring compliance with temperature-sensitive requirements for pharmaceuticals and food storage.

PHȲND operates a free, subscription-free cloud gaming platform designed for instant play on Smart TVs without requiring downloads or consoles. The platform offers developers one-time integration for broad distribution across various Smart TV operating systems, supporting multiple controller types. It provides built-in monetization through ads and in-game transactions, alongside marketing and engagement tools to help developers reach players.

Pryon provides an Enterprise Memory layer to accelerate the deployment of accurate, production-ready Generative AI agents and applications. The platform unifies enterprise intelligence and grounds AI models using Retrieval-Augmented Generation (RAG) against trusted data sources. It manages complex data preparation, indexing, and dynamic retrieval to ensure secure, context-aware AI performance.

Re is an on‑chain reinsurance protocol that tokenizes real reinsurance treaties, issuing fully collateralized tokens backed by verified insurance premiums. The platform provides institutional investors and insurers with regulated, transparent access to the $800B+ reinsurance market, delivering 8‑16% annual yields that are largely uncorrelated with traditional assets while maintaining defined risk limits and underwriting discipline.

Rediscovery Life Sciences utilizes drug repurposing to develop biopharmaceuticals with reduced safety risks and improved efficacy profiles. This approach addresses the high failure rates and lengthy timelines associated with traditional drug development by leveraging existing medications for new therapeutic uses.

Provides AI-powered software for evaluating and optimizing EV charging station networks by analyzing real utilization data, load curves, and energy costs. This platform helps operators increase site profitability, forecast demand at the address level, and achieve up to 3x higher ROI by reducing underutilization and de-risking infrastructure investments.

Synaptrix offers NOVABLOC, a drug-free solution for managing postoperative pain through targeted nerve block technology. This approach reduces reliance on opioids, minimizing the risk of addiction and enhancing patient recovery experiences.

Vergent Bioscience develops VGT-309, a tumor-targeted fluorescent imaging agent designed to enhance real-time visualization of tumors during minimally invasive and robotic-assisted cancer surgeries. This technology addresses the challenge of detecting previously undetected tumors, ensuring complete tumor removal and improving surgical outcomes for patients with solid tumors.